Experts from EMA visited BravoVax
Author:超级管理员 Release time:2017-02-13 23:13:39
On February 13rd, 2017, experts from European Medicines Agency visited BravoVax and met its managing leaderships in a relaxed atmosphere. The EMA experts will stay for 1 week in BravoVax and give technical verification opinions.
In the meeting, CSO Michel of BravoVax addressed future development planning for the company, Project Manager addressed R&D pipeline of BravoVax and Public Affairs Director addressed the project plan for overseas registration. After the meeting, experts from EMA visited the labs and office facilities of BravoVax.
